Global Tick-borne Encephalitis Vaccine Market Growth 2025-2031
The global Tick-borne Encephalitis Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The major factors that drive the growth of global tick-borne encephalitis vaccine, inactivated market is rise in prevalence of tick-borne encephalitis, especially in Europe, and increased government funding on healthcare facilities. In addition, increase in drug development owing to technological advancement in the medical sector fuels the market growth. However, high cost of vaccines is the major restraint of the market. On the contrary, untapped economies with unmet medical needs is anticipated to provide lucrative opportunities for market growth.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Tick-borne Encephalitis Vaccine Industry Forecast” looks at past sales and reviews total world Tick-borne Encephalitis Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Tick-borne Encephalitis Vaccine sales for 2025 through 2031. With Tick-borne Encephalitis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tick-borne Encephalitis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Tick-borne Encephalitis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tick-borne Encephalitis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tick-borne Encephalitis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tick-borne Encephalitis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tick-borne Encephalitis Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Tick-borne Encephalitis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Tick-borne Encephalitis Vaccine market?
What factors are driving Tick-borne Encephalitis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tick-borne Encephalitis Vaccine market opportunities vary by end market size?
How does Tick-borne Encephalitis Vaccine break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The major factors that drive the growth of global tick-borne encephalitis vaccine, inactivated market is rise in prevalence of tick-borne encephalitis, especially in Europe, and increased government funding on healthcare facilities. In addition, increase in drug development owing to technological advancement in the medical sector fuels the market growth. However, high cost of vaccines is the major restraint of the market. On the contrary, untapped economies with unmet medical needs is anticipated to provide lucrative opportunities for market growth.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Tick-borne Encephalitis Vaccine Industry Forecast” looks at past sales and reviews total world Tick-borne Encephalitis Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Tick-borne Encephalitis Vaccine sales for 2025 through 2031. With Tick-borne Encephalitis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tick-borne Encephalitis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Tick-borne Encephalitis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tick-borne Encephalitis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tick-borne Encephalitis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tick-borne Encephalitis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tick-borne Encephalitis Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Tick-borne Encephalitis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- European TBE Virus
- Far Eastern TBE Virus
- Siberian TBE Virus
- Pediatric Vaccines
- Adult Vaccines
- Traveler Vaccines
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Encephalitis
- Cochrane Collaboration
- Sonic HealthPlus
- Superdrug Health
What is the 10-year outlook for the global Tick-borne Encephalitis Vaccine market?
What factors are driving Tick-borne Encephalitis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tick-borne Encephalitis Vaccine market opportunities vary by end market size?
How does Tick-borne Encephalitis Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Vaccination Market Size (2020-2031)
2.1.2 Influenza Vaccination Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Influenza Vaccination by Country/Region (2020, 2024 & 2031)
2.2 Influenza Vaccination Segment by Type
2.2.1 Egg Based
2.2.2 Cell Culture
2.2.3 Recombinant
2.3 Influenza Vaccination Market Size by Type
2.3.1 Influenza Vaccination Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Influenza Vaccination Market Size Market Share by Type (2020-2025)
2.4 Influenza Vaccination Segment by Application
2.4.1 Hospitals
2.4.2 Research Organizations
2.5 Influenza Vaccination Market Size by Application
2.5.1 Influenza Vaccination Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Influenza Vaccination Market Size Market Share by Application (2020-2025)
3 INFLUENZA VACCINATION MARKET SIZE BY PLAYER
3.1 Influenza Vaccination Market Size Market Share by Player
3.1.1 Global Influenza Vaccination Revenue by Player (2020-2025)
3.1.2 Global Influenza Vaccination Revenue Market Share by Player (2020-2025)
3.2 Global Influenza Vaccination Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFLUENZA VACCINATION BY REGION
4.1 Influenza Vaccination Market Size by Region (2020-2025)
4.2 Global Influenza Vaccination Annual Revenue by Country/Region (2020-2025)
4.3 Americas Influenza Vaccination Market Size Growth (2020-2025)
4.4 APAC Influenza Vaccination Market Size Growth (2020-2025)
4.5 Europe Influenza Vaccination Market Size Growth (2020-2025)
4.6 Middle East & Africa Influenza Vaccination Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Influenza Vaccination Market Size by Country (2020-2025)
5.2 Americas Influenza Vaccination Market Size by Type (2020-2025)
5.3 Americas Influenza Vaccination Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Vaccination Market Size by Region (2020-2025)
6.2 APAC Influenza Vaccination Market Size by Type (2020-2025)
6.3 APAC Influenza Vaccination Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Influenza Vaccination Market Size by Country (2020-2025)
7.2 Europe Influenza Vaccination Market Size by Type (2020-2025)
7.3 Europe Influenza Vaccination Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Vaccination by Region (2020-2025)
8.2 Middle East & Africa Influenza Vaccination Market Size by Type (2020-2025)
8.3 Middle East & Africa Influenza Vaccination Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFLUENZA VACCINATION MARKET FORECAST
10.1 Global Influenza Vaccination Forecast by Region (2026-2031)
10.1.1 Global Influenza Vaccination Forecast by Region (2026-2031)
10.1.2 Americas Influenza Vaccination Forecast
10.1.3 APAC Influenza Vaccination Forecast
10.1.4 Europe Influenza Vaccination Forecast
10.1.5 Middle East & Africa Influenza Vaccination Forecast
10.2 Americas Influenza Vaccination Forecast by Country (2026-2031)
10.2.1 United States Market Influenza Vaccination Forecast
10.2.2 Canada Market Influenza Vaccination Forecast
10.2.3 Mexico Market Influenza Vaccination Forecast
10.2.4 Brazil Market Influenza Vaccination Forecast
10.3 APAC Influenza Vaccination Forecast by Region (2026-2031)
10.3.1 China Influenza Vaccination Market Forecast
10.3.2 Japan Market Influenza Vaccination Forecast
10.3.3 Korea Market Influenza Vaccination Forecast
10.3.4 Southeast Asia Market Influenza Vaccination Forecast
10.3.5 India Market Influenza Vaccination Forecast
10.3.6 Australia Market Influenza Vaccination Forecast
10.4 Europe Influenza Vaccination Forecast by Country (2026-2031)
10.4.1 Germany Market Influenza Vaccination Forecast
10.4.2 France Market Influenza Vaccination Forecast
10.4.3 UK Market Influenza Vaccination Forecast
10.4.4 Italy Market Influenza Vaccination Forecast
10.4.5 Russia Market Influenza Vaccination Forecast
10.5 Middle East & Africa Influenza Vaccination Forecast by Region (2026-2031)
10.5.1 Egypt Market Influenza Vaccination Forecast
10.5.2 South Africa Market Influenza Vaccination Forecast
10.5.3 Israel Market Influenza Vaccination Forecast
10.5.4 Turkey Market Influenza Vaccination Forecast
10.6 Global Influenza Vaccination Forecast by Type (2026-2031)
10.7 Global Influenza Vaccination Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Influenza Vaccination Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott (U.S.)
11.1.1 Abbott (U.S.) Company Information
11.1.2 Abbott (U.S.) Influenza Vaccination Product Offered
11.1.3 Abbott (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott (U.S.) Main Business Overview
11.1.5 Abbott (U.S.) Latest Developments
11.2 AstraZeneca (Europe)
11.2.1 AstraZeneca (Europe) Company Information
11.2.2 AstraZeneca (Europe) Influenza Vaccination Product Offered
11.2.3 AstraZeneca (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 AstraZeneca (Europe) Main Business Overview
11.2.5 AstraZeneca (Europe) Latest Developments
11.3 BioCryst Pharmaceuticals (U.S.)
11.3.1 BioCryst Pharmaceuticals (U.S.) Company Information
11.3.2 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product Offered
11.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 BioCryst Pharmaceuticals (U.S.) Main Business Overview
11.3.5 BioCryst Pharmaceuticals (U.S.) Latest Developments
11.4 Novartis (Europe)
11.4.1 Novartis (Europe) Company Information
11.4.2 Novartis (Europe) Influenza Vaccination Product Offered
11.4.3 Novartis (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis (Europe) Main Business Overview
11.4.5 Novartis (Europe) Latest Developments
11.5 DAIICHI SANKYO COMPANY (Asia Pacific)
11.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Company Information
11.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product Offered
11.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Main Business Overview
11.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Latest Developments
11.6 GlaxoSmithKline (Europe)
11.6.1 GlaxoSmithKline (Europe) Company Information
11.6.2 GlaxoSmithKline (Europe) Influenza Vaccination Product Offered
11.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 GlaxoSmithKline (Europe) Main Business Overview
11.6.5 GlaxoSmithKline (Europe) Latest Developments
11.7 Hualan Biological Engineering (Asia Pacific)
11.7.1 Hualan Biological Engineering (Asia Pacific) Company Information
11.7.2 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product Offered
11.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Hualan Biological Engineering (Asia Pacific) Main Business Overview
11.7.5 Hualan Biological Engineering (Asia Pacific) Latest Developments
11.8 Mitsubishi Tanabe Pharma (Asia Pacific)
11.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Company Information
11.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product Offered
11.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Main Business Overview
11.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Latest Developments
11.9 F. Hoffmann-La Roche (Europe)
11.9.1 F. Hoffmann-La Roche (Europe) Company Information
11.9.2 F. Hoffmann-La Roche (Europe) Influenza Vaccination Product Offered
11.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 F. Hoffmann-La Roche (Europe) Main Business Overview
11.9.5 F. Hoffmann-La Roche (Europe) Latest Developments
11.10 Sanofi (Europe)
11.10.1 Sanofi (Europe) Company Information
11.10.2 Sanofi (Europe) Influenza Vaccination Product Offered
11.10.3 Sanofi (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Sanofi (Europe) Main Business Overview
11.10.5 Sanofi (Europe) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Vaccination Market Size (2020-2031)
2.1.2 Influenza Vaccination Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Influenza Vaccination by Country/Region (2020, 2024 & 2031)
2.2 Influenza Vaccination Segment by Type
2.2.1 Egg Based
2.2.2 Cell Culture
2.2.3 Recombinant
2.3 Influenza Vaccination Market Size by Type
2.3.1 Influenza Vaccination Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Influenza Vaccination Market Size Market Share by Type (2020-2025)
2.4 Influenza Vaccination Segment by Application
2.4.1 Hospitals
2.4.2 Research Organizations
2.5 Influenza Vaccination Market Size by Application
2.5.1 Influenza Vaccination Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Influenza Vaccination Market Size Market Share by Application (2020-2025)
3 INFLUENZA VACCINATION MARKET SIZE BY PLAYER
3.1 Influenza Vaccination Market Size Market Share by Player
3.1.1 Global Influenza Vaccination Revenue by Player (2020-2025)
3.1.2 Global Influenza Vaccination Revenue Market Share by Player (2020-2025)
3.2 Global Influenza Vaccination Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFLUENZA VACCINATION BY REGION
4.1 Influenza Vaccination Market Size by Region (2020-2025)
4.2 Global Influenza Vaccination Annual Revenue by Country/Region (2020-2025)
4.3 Americas Influenza Vaccination Market Size Growth (2020-2025)
4.4 APAC Influenza Vaccination Market Size Growth (2020-2025)
4.5 Europe Influenza Vaccination Market Size Growth (2020-2025)
4.6 Middle East & Africa Influenza Vaccination Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Influenza Vaccination Market Size by Country (2020-2025)
5.2 Americas Influenza Vaccination Market Size by Type (2020-2025)
5.3 Americas Influenza Vaccination Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Vaccination Market Size by Region (2020-2025)
6.2 APAC Influenza Vaccination Market Size by Type (2020-2025)
6.3 APAC Influenza Vaccination Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Influenza Vaccination Market Size by Country (2020-2025)
7.2 Europe Influenza Vaccination Market Size by Type (2020-2025)
7.3 Europe Influenza Vaccination Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Vaccination by Region (2020-2025)
8.2 Middle East & Africa Influenza Vaccination Market Size by Type (2020-2025)
8.3 Middle East & Africa Influenza Vaccination Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFLUENZA VACCINATION MARKET FORECAST
10.1 Global Influenza Vaccination Forecast by Region (2026-2031)
10.1.1 Global Influenza Vaccination Forecast by Region (2026-2031)
10.1.2 Americas Influenza Vaccination Forecast
10.1.3 APAC Influenza Vaccination Forecast
10.1.4 Europe Influenza Vaccination Forecast
10.1.5 Middle East & Africa Influenza Vaccination Forecast
10.2 Americas Influenza Vaccination Forecast by Country (2026-2031)
10.2.1 United States Market Influenza Vaccination Forecast
10.2.2 Canada Market Influenza Vaccination Forecast
10.2.3 Mexico Market Influenza Vaccination Forecast
10.2.4 Brazil Market Influenza Vaccination Forecast
10.3 APAC Influenza Vaccination Forecast by Region (2026-2031)
10.3.1 China Influenza Vaccination Market Forecast
10.3.2 Japan Market Influenza Vaccination Forecast
10.3.3 Korea Market Influenza Vaccination Forecast
10.3.4 Southeast Asia Market Influenza Vaccination Forecast
10.3.5 India Market Influenza Vaccination Forecast
10.3.6 Australia Market Influenza Vaccination Forecast
10.4 Europe Influenza Vaccination Forecast by Country (2026-2031)
10.4.1 Germany Market Influenza Vaccination Forecast
10.4.2 France Market Influenza Vaccination Forecast
10.4.3 UK Market Influenza Vaccination Forecast
10.4.4 Italy Market Influenza Vaccination Forecast
10.4.5 Russia Market Influenza Vaccination Forecast
10.5 Middle East & Africa Influenza Vaccination Forecast by Region (2026-2031)
10.5.1 Egypt Market Influenza Vaccination Forecast
10.5.2 South Africa Market Influenza Vaccination Forecast
10.5.3 Israel Market Influenza Vaccination Forecast
10.5.4 Turkey Market Influenza Vaccination Forecast
10.6 Global Influenza Vaccination Forecast by Type (2026-2031)
10.7 Global Influenza Vaccination Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Influenza Vaccination Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott (U.S.)
11.1.1 Abbott (U.S.) Company Information
11.1.2 Abbott (U.S.) Influenza Vaccination Product Offered
11.1.3 Abbott (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott (U.S.) Main Business Overview
11.1.5 Abbott (U.S.) Latest Developments
11.2 AstraZeneca (Europe)
11.2.1 AstraZeneca (Europe) Company Information
11.2.2 AstraZeneca (Europe) Influenza Vaccination Product Offered
11.2.3 AstraZeneca (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 AstraZeneca (Europe) Main Business Overview
11.2.5 AstraZeneca (Europe) Latest Developments
11.3 BioCryst Pharmaceuticals (U.S.)
11.3.1 BioCryst Pharmaceuticals (U.S.) Company Information
11.3.2 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product Offered
11.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 BioCryst Pharmaceuticals (U.S.) Main Business Overview
11.3.5 BioCryst Pharmaceuticals (U.S.) Latest Developments
11.4 Novartis (Europe)
11.4.1 Novartis (Europe) Company Information
11.4.2 Novartis (Europe) Influenza Vaccination Product Offered
11.4.3 Novartis (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis (Europe) Main Business Overview
11.4.5 Novartis (Europe) Latest Developments
11.5 DAIICHI SANKYO COMPANY (Asia Pacific)
11.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Company Information
11.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product Offered
11.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Main Business Overview
11.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Latest Developments
11.6 GlaxoSmithKline (Europe)
11.6.1 GlaxoSmithKline (Europe) Company Information
11.6.2 GlaxoSmithKline (Europe) Influenza Vaccination Product Offered
11.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 GlaxoSmithKline (Europe) Main Business Overview
11.6.5 GlaxoSmithKline (Europe) Latest Developments
11.7 Hualan Biological Engineering (Asia Pacific)
11.7.1 Hualan Biological Engineering (Asia Pacific) Company Information
11.7.2 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product Offered
11.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Hualan Biological Engineering (Asia Pacific) Main Business Overview
11.7.5 Hualan Biological Engineering (Asia Pacific) Latest Developments
11.8 Mitsubishi Tanabe Pharma (Asia Pacific)
11.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Company Information
11.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product Offered
11.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Main Business Overview
11.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Latest Developments
11.9 F. Hoffmann-La Roche (Europe)
11.9.1 F. Hoffmann-La Roche (Europe) Company Information
11.9.2 F. Hoffmann-La Roche (Europe) Influenza Vaccination Product Offered
11.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 F. Hoffmann-La Roche (Europe) Main Business Overview
11.9.5 F. Hoffmann-La Roche (Europe) Latest Developments
11.10 Sanofi (Europe)
11.10.1 Sanofi (Europe) Company Information
11.10.2 Sanofi (Europe) Influenza Vaccination Product Offered
11.10.3 Sanofi (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Sanofi (Europe) Main Business Overview
11.10.5 Sanofi (Europe) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tick-borne Encephalitis Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Tick-borne Encephalitis Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of European TBE Virus
Table 4. Major Players of Far Eastern TBE Virus
Table 5. Major Players of Siberian TBE Virus
Table 6. Global Tick-borne Encephalitis Vaccine Sales by Type (2020-2025) & (K Doses)
Table 7. Global Tick-borne Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Table 8. Global Tick-borne Encephalitis Vaccine Revenue by Type (2020-2025) & ($ million)
Table 9. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2020-2025)
Table 10. Global Tick-borne Encephalitis Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 11. Global Tick-borne Encephalitis Vaccine Sale by Application (2020-2025) & (K Doses)
Table 12. Global Tick-borne Encephalitis Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global Tick-borne Encephalitis Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Tick-borne Encephalitis Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 16. Global Tick-borne Encephalitis Vaccine Sales by Company (2020-2025) & (K Doses)
Table 17. Global Tick-borne Encephalitis Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Tick-borne Encephalitis Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Tick-borne Encephalitis Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 21. Key Manufacturers Tick-borne Encephalitis Vaccine Producing Area Distribution and Sales Area
Table 22. Players Tick-borne Encephalitis Vaccine Products Offered
Table 23. Tick-borne Encephalitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Tick-borne Encephalitis Vaccine Sales by Geographic Region (2020-2025) & (K Doses)
Table 27. Global Tick-borne Encephalitis Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Tick-borne Encephalitis Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Tick-borne Encephalitis Vaccine Sales by Country/Region (2020-2025) & (K Doses)
Table 31. Global Tick-borne Encephalitis Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Tick-borne Encephalitis Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Tick-borne Encephalitis Vaccine Sales by Country (2020-2025) & (K Doses)
Table 35. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Tick-borne Encephalitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Tick-borne Encephalitis Vaccine Sales by Type (2020-2025) & (K Doses)
Table 38. Americas Tick-borne Encephalitis Vaccine Sales by Application (2020-2025) & (K Doses)
Table 39. APAC Tick-borne Encephalitis Vaccine Sales by Region (2020-2025) & (K Doses)
Table 40. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Tick-borne Encephalitis Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Tick-borne Encephalitis Vaccine Sales by Type (2020-2025) & (K Doses)
Table 43. APAC Tick-borne Encephalitis Vaccine Sales by Application (2020-2025) & (K Doses)
Table 44. Europe Tick-borne Encephalitis Vaccine Sales by Country (2020-2025) & (K Doses)
Table 45. Europe Tick-borne Encephalitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Tick-borne Encephalitis Vaccine Sales by Type (2020-2025) & (K Doses)
Table 47. Europe Tick-borne Encephalitis Vaccine Sales by Application (2020-2025) & (K Doses)
Table 48. Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Country (2020-2025) & (K Doses)
Table 49. Middle East & Africa Tick-borne Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Type (2020-2025) & (K Doses)
Table 51. Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Application (2020-2025) & (K Doses)
Table 52. Key Market Drivers & Growth Opportunities of Tick-borne Encephalitis Vaccine
Table 53. Key Market Challenges & Risks of Tick-borne Encephalitis Vaccine
Table 54. Key Industry Trends of Tick-borne Encephalitis Vaccine
Table 55. Tick-borne Encephalitis Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Tick-borne Encephalitis Vaccine Distributors List
Table 58. Tick-borne Encephalitis Vaccine Customer List
Table 59. Global Tick-borne Encephalitis Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 60. Global Tick-borne Encephalitis Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Tick-borne Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 62. Americas Tick-borne Encephalitis Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Tick-borne Encephalitis Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 64. APAC Tick-borne Encephalitis Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Tick-borne Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 66. Europe Tick-borne Encephalitis Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 68. Middle East & Africa Tick-borne Encephalitis Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Tick-borne Encephalitis Vaccine Sales Forecast by Type (2026-2031) & (K Doses)
Table 70. Global Tick-borne Encephalitis Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Tick-borne Encephalitis Vaccine Sales Forecast by Application (2026-2031) & (K Doses)
Table 72. Global Tick-borne Encephalitis Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Pfizer Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Tick-borne Encephalitis Vaccine Product Portfolios and Specifications
Table 75. Pfizer Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Encephalitis Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Encephalitis Tick-borne Encephalitis Vaccine Product Portfolios and Specifications
Table 80. Encephalitis Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. Encephalitis Main Business
Table 82. Encephalitis Latest Developments
Table 83. Cochrane Collaboration Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Cochrane Collaboration Tick-borne Encephalitis Vaccine Product Portfolios and Specifications
Table 85. Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. Cochrane Collaboration Main Business
Table 87. Cochrane Collaboration Latest Developments
Table 88. Sonic HealthPlus Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Sonic HealthPlus Tick-borne Encephalitis Vaccine Product Portfolios and Specifications
Table 90. Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. Sonic HealthPlus Main Business
Table 92. Sonic HealthPlus Latest Developments
Table 93. Superdrug Health Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Superdrug Health Tick-borne Encephalitis Vaccine Product Portfolios and Specifications
Table 95. Superdrug Health Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Superdrug Health Main Business
Table 97. Superdrug Health Latest Developments
Table 1. Tick-borne Encephalitis Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Tick-borne Encephalitis Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of European TBE Virus
Table 4. Major Players of Far Eastern TBE Virus
Table 5. Major Players of Siberian TBE Virus
Table 6. Global Tick-borne Encephalitis Vaccine Sales by Type (2020-2025) & (K Doses)
Table 7. Global Tick-borne Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Table 8. Global Tick-borne Encephalitis Vaccine Revenue by Type (2020-2025) & ($ million)
Table 9. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2020-2025)
Table 10. Global Tick-borne Encephalitis Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 11. Global Tick-borne Encephalitis Vaccine Sale by Application (2020-2025) & (K Doses)
Table 12. Global Tick-borne Encephalitis Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global Tick-borne Encephalitis Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Tick-borne Encephalitis Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 16. Global Tick-borne Encephalitis Vaccine Sales by Company (2020-2025) & (K Doses)
Table 17. Global Tick-borne Encephalitis Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Tick-borne Encephalitis Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Tick-borne Encephalitis Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 21. Key Manufacturers Tick-borne Encephalitis Vaccine Producing Area Distribution and Sales Area
Table 22. Players Tick-borne Encephalitis Vaccine Products Offered
Table 23. Tick-borne Encephalitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Tick-borne Encephalitis Vaccine Sales by Geographic Region (2020-2025) & (K Doses)
Table 27. Global Tick-borne Encephalitis Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Tick-borne Encephalitis Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Tick-borne Encephalitis Vaccine Sales by Country/Region (2020-2025) & (K Doses)
Table 31. Global Tick-borne Encephalitis Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Tick-borne Encephalitis Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Tick-borne Encephalitis Vaccine Sales by Country (2020-2025) & (K Doses)
Table 35. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Tick-borne Encephalitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Tick-borne Encephalitis Vaccine Sales by Type (2020-2025) & (K Doses)
Table 38. Americas Tick-borne Encephalitis Vaccine Sales by Application (2020-2025) & (K Doses)
Table 39. APAC Tick-borne Encephalitis Vaccine Sales by Region (2020-2025) & (K Doses)
Table 40. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Tick-borne Encephalitis Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Tick-borne Encephalitis Vaccine Sales by Type (2020-2025) & (K Doses)
Table 43. APAC Tick-borne Encephalitis Vaccine Sales by Application (2020-2025) & (K Doses)
Table 44. Europe Tick-borne Encephalitis Vaccine Sales by Country (2020-2025) & (K Doses)
Table 45. Europe Tick-borne Encephalitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Tick-borne Encephalitis Vaccine Sales by Type (2020-2025) & (K Doses)
Table 47. Europe Tick-borne Encephalitis Vaccine Sales by Application (2020-2025) & (K Doses)
Table 48. Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Country (2020-2025) & (K Doses)
Table 49. Middle East & Africa Tick-borne Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Type (2020-2025) & (K Doses)
Table 51. Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Application (2020-2025) & (K Doses)
Table 52. Key Market Drivers & Growth Opportunities of Tick-borne Encephalitis Vaccine
Table 53. Key Market Challenges & Risks of Tick-borne Encephalitis Vaccine
Table 54. Key Industry Trends of Tick-borne Encephalitis Vaccine
Table 55. Tick-borne Encephalitis Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Tick-borne Encephalitis Vaccine Distributors List
Table 58. Tick-borne Encephalitis Vaccine Customer List
Table 59. Global Tick-borne Encephalitis Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 60. Global Tick-borne Encephalitis Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Tick-borne Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 62. Americas Tick-borne Encephalitis Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Tick-borne Encephalitis Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 64. APAC Tick-borne Encephalitis Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Tick-borne Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 66. Europe Tick-borne Encephalitis Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 68. Middle East & Africa Tick-borne Encephalitis Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Tick-borne Encephalitis Vaccine Sales Forecast by Type (2026-2031) & (K Doses)
Table 70. Global Tick-borne Encephalitis Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Tick-borne Encephalitis Vaccine Sales Forecast by Application (2026-2031) & (K Doses)
Table 72. Global Tick-borne Encephalitis Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Pfizer Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Tick-borne Encephalitis Vaccine Product Portfolios and Specifications
Table 75. Pfizer Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Encephalitis Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Encephalitis Tick-borne Encephalitis Vaccine Product Portfolios and Specifications
Table 80. Encephalitis Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. Encephalitis Main Business
Table 82. Encephalitis Latest Developments
Table 83. Cochrane Collaboration Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Cochrane Collaboration Tick-borne Encephalitis Vaccine Product Portfolios and Specifications
Table 85. Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. Cochrane Collaboration Main Business
Table 87. Cochrane Collaboration Latest Developments
Table 88. Sonic HealthPlus Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Sonic HealthPlus Tick-borne Encephalitis Vaccine Product Portfolios and Specifications
Table 90. Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. Sonic HealthPlus Main Business
Table 92. Sonic HealthPlus Latest Developments
Table 93. Superdrug Health Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Superdrug Health Tick-borne Encephalitis Vaccine Product Portfolios and Specifications
Table 95. Superdrug Health Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Superdrug Health Main Business
Table 97. Superdrug Health Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tick-borne Encephalitis Vaccine
Figure 2. Tick-borne Encephalitis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tick-borne Encephalitis Vaccine Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Tick-borne Encephalitis Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Tick-borne Encephalitis Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Tick-borne Encephalitis Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Tick-borne Encephalitis Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of European TBE Virus
Figure 12. Product Picture of Far Eastern TBE Virus
Figure 13. Product Picture of Siberian TBE Virus
Figure 14. Global Tick-borne Encephalitis Vaccine Sales Market Share by Type in 2025
Figure 15. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2020-2025)
Figure 16. Tick-borne Encephalitis Vaccine Consumed in Pediatric Vaccines
Figure 17. Global Tick-borne Encephalitis Vaccine Market: Pediatric Vaccines (2020-2025) & (K Doses)
Figure 18. Tick-borne Encephalitis Vaccine Consumed in Adult Vaccines
Figure 19. Global Tick-borne Encephalitis Vaccine Market: Adult Vaccines (2020-2025) & (K Doses)
Figure 20. Tick-borne Encephalitis Vaccine Consumed in Traveler Vaccines
Figure 21. Global Tick-borne Encephalitis Vaccine Market: Traveler Vaccines (2020-2025) & (K Doses)
Figure 22. Global Tick-borne Encephalitis Vaccine Sale Market Share by Application (2024)
Figure 23. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Application in 2025
Figure 24. Tick-borne Encephalitis Vaccine Sales by Company in 2025 (K Doses)
Figure 25. Global Tick-borne Encephalitis Vaccine Sales Market Share by Company in 2025
Figure 26. Tick-borne Encephalitis Vaccine Revenue by Company in 2025 ($ millions)
Figure 27. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Company in 2025
Figure 28. Global Tick-borne Encephalitis Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Tick-borne Encephalitis Vaccine Sales 2020-2025 (K Doses)
Figure 31. Americas Tick-borne Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 32. APAC Tick-borne Encephalitis Vaccine Sales 2020-2025 (K Doses)
Figure 33. APAC Tick-borne Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 34. Europe Tick-borne Encephalitis Vaccine Sales 2020-2025 (K Doses)
Figure 35. Europe Tick-borne Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Tick-borne Encephalitis Vaccine Sales 2020-2025 (K Doses)
Figure 37. Middle East & Africa Tick-borne Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 38. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Country in 2025
Figure 39. Americas Tick-borne Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 40. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 41. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 42. United States Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Region in 2025
Figure 47. APAC Tick-borne Encephalitis Vaccine Revenue Market Share by Region (2020-2025)
Figure 48. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 49. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 50. China Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. India Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Country in 2025
Figure 58. Europe Tick-borne Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 59. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 60. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 61. Germany Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. France Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 69. Egypt Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Tick-borne Encephalitis Vaccine in 2025
Figure 75. Manufacturing Process Analysis of Tick-borne Encephalitis Vaccine
Figure 76. Industry Chain Structure of Tick-borne Encephalitis Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Tick-borne Encephalitis Vaccine Sales Market Forecast by Region (2026-2031)
Figure 79. Global Tick-borne Encephalitis Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Tick-borne Encephalitis Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Tick-borne Encephalitis Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Tick-borne Encephalitis Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Tick-borne Encephalitis Vaccine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Tick-borne Encephalitis Vaccine
Figure 2. Tick-borne Encephalitis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tick-borne Encephalitis Vaccine Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Tick-borne Encephalitis Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Tick-borne Encephalitis Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Tick-borne Encephalitis Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Tick-borne Encephalitis Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of European TBE Virus
Figure 12. Product Picture of Far Eastern TBE Virus
Figure 13. Product Picture of Siberian TBE Virus
Figure 14. Global Tick-borne Encephalitis Vaccine Sales Market Share by Type in 2025
Figure 15. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2020-2025)
Figure 16. Tick-borne Encephalitis Vaccine Consumed in Pediatric Vaccines
Figure 17. Global Tick-borne Encephalitis Vaccine Market: Pediatric Vaccines (2020-2025) & (K Doses)
Figure 18. Tick-borne Encephalitis Vaccine Consumed in Adult Vaccines
Figure 19. Global Tick-borne Encephalitis Vaccine Market: Adult Vaccines (2020-2025) & (K Doses)
Figure 20. Tick-borne Encephalitis Vaccine Consumed in Traveler Vaccines
Figure 21. Global Tick-borne Encephalitis Vaccine Market: Traveler Vaccines (2020-2025) & (K Doses)
Figure 22. Global Tick-borne Encephalitis Vaccine Sale Market Share by Application (2024)
Figure 23. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Application in 2025
Figure 24. Tick-borne Encephalitis Vaccine Sales by Company in 2025 (K Doses)
Figure 25. Global Tick-borne Encephalitis Vaccine Sales Market Share by Company in 2025
Figure 26. Tick-borne Encephalitis Vaccine Revenue by Company in 2025 ($ millions)
Figure 27. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Company in 2025
Figure 28. Global Tick-borne Encephalitis Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Tick-borne Encephalitis Vaccine Sales 2020-2025 (K Doses)
Figure 31. Americas Tick-borne Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 32. APAC Tick-borne Encephalitis Vaccine Sales 2020-2025 (K Doses)
Figure 33. APAC Tick-borne Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 34. Europe Tick-borne Encephalitis Vaccine Sales 2020-2025 (K Doses)
Figure 35. Europe Tick-borne Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Tick-borne Encephalitis Vaccine Sales 2020-2025 (K Doses)
Figure 37. Middle East & Africa Tick-borne Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 38. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Country in 2025
Figure 39. Americas Tick-borne Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 40. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 41. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 42. United States Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Region in 2025
Figure 47. APAC Tick-borne Encephalitis Vaccine Revenue Market Share by Region (2020-2025)
Figure 48. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 49. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 50. China Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. India Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Country in 2025
Figure 58. Europe Tick-borne Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 59. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 60. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 61. Germany Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. France Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 69. Egypt Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Tick-borne Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Tick-borne Encephalitis Vaccine in 2025
Figure 75. Manufacturing Process Analysis of Tick-borne Encephalitis Vaccine
Figure 76. Industry Chain Structure of Tick-borne Encephalitis Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Tick-borne Encephalitis Vaccine Sales Market Forecast by Region (2026-2031)
Figure 79. Global Tick-borne Encephalitis Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Tick-borne Encephalitis Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Tick-borne Encephalitis Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Tick-borne Encephalitis Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Tick-borne Encephalitis Vaccine Revenue Market Share Forecast by Application (2026-2031)
